Zhijuan Liu

机构：Guangzhou University of Chinese Medicine, Xinjiang Medical University, First Affiliated Hospital of Xinjiang Medical University, Shandong Tumor Hospital, Shandong Provincial Hospital, Shandong First Medical University · ORCID：0000-0002-5777-8839

发表论文 38 篇 · 总被引 479 次 · h-index 11

代表论文

• Tussilagone inhibits osteoclastogenesis by modulating mitochondrial function and ROS production involved Nrf2 activation (2023 · Biochemical Pharmacology · 被引 31)
• Dauricine attenuates ovariectomized-induced bone loss and RANKL-induced osteoclastogenesis via inhibiting ROS-mediated NF-κB and NFATc1 activity (2024 · Phytomedicine · 被引 19)
• Chronic intermittent hypoxia‐induced oxidative stress activates TRB3 and phosphorylated JNK to mediate insulin resistance and cell apoptosis in the pancreas (2024 · Clinical and Experimental Pharmacology and Physiology · 被引 17)
• Traditional Chinese medicine improves myasthenia gravis by regulating the symbiotic homeostasis of the intestinal microbiota and host (2023 · Frontiers in Microbiology · 被引 11)
• A mutation of EYA1 gene in a Chinese Han family with Branchio-Oto syndrome (2021 · Medicine · 被引 11)
• Hecogenin alleviates LPS-induced osteolysis via regulating pyroptosis and ROS involved Nrf2 activation (2024 · Biomedicine & Pharmacotherapy · 被引 9)